Home
Home

FDA

Salix, Progenics shares rise after FDA panel says it will review constipation drug Relistor

Salix, Progenics shares rise after FDA panel says it will review constipation drug Relistor
Yahoo/AP

FDA warning letter cites Baxter for mold at plant, hair in infusion products

FDA warning letter cites Baxter for mold at plant, hair in infusion products
Fierce Pharma

Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN® (lucinactant) Updated Product Specifications

Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN® (lucinactant) Updated Product Specifications
CP Wire

FDA rejects Aveo kidney cancer drug, asks for additional trial

FDA rejects Aveo kidney cancer drug, asks for additional trial
Reuters

Sanofi announces FDA approved sBLA for licensure of influenza vaccine

Sanofi announces FDA approved sBLA for licensure of influenza vaccine
Yahoo/Fly on the Wall
Submitted by Pitch360 on Mon, 06/10/2013 - 10:31

Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN® (lucinactant) Updated Product Specifications

Discovery Labs Responds to FDA Request for Clarification of Recently
Submitted SURFAXIN® (lucinactant) Updated Product Specifications

»

FDA asks for more safety data on Dynavax's hepatitis B vaccine

FDA asks for more safety data on Dynavax's hepatitis B vaccine
Reuters

FDA Advisory Panel Backs Looser Restrictions On Avandia

FDA Advisory Panel Backs Looser Restrictions On Avandia
Forbes

As If Amarin Needs Another Worry, Here Comes A Vascepa FDA Panel

As If Amarin Needs Another Worry, Here Comes A Vascepa FDA Panel
TheStreet.com

U.S. FDA panel revisits Avandia, likely too late for diabetes drug

U.S. FDA panel revisits Avandia, likely too late for diabetes drug
Reuters